Indication
Heart Failure With Reduced Ejection Fraction
1 clinical trial
2 products
Clinical trial
A Phase 1/2 Trial of the Safety and Efficacy of SRD-001 (AAV1/SERCA2a) in Subjects With Heart Failure With Reduced Ejection FractionStatus: Recruiting, Estimated PCD: 2025-12-31
Product
PlaceboProduct
SRD-001